The Board of Directors of Hemfosa Fastigheter AB (publ) (”Hemfosa” or ”the Company”) has resolved, with authorization granted by Hemfosa´s Extraordinary General Meeting on 12 November, 2014, to carry out an issue of preference shares. The offer in brief: · The offer is directed to the general public in Sweden and to institutional investors in Sweden and internationally, including Hemfosa’s existing shareholders (“the Offer”) · The subscription price has been set to SEK 325 per preference share and the yearly dividend amounts to SEK 20 per preference share, implying an annual yield for the preference shares of 6.2 per cent · The Offer amounts up to a total of SEK 975m before issue expenses. If there is a strong demand, the Offer may be increased by an additional amount of up to SEK 650m · The subscription period runs from 21 November, 2014 until 2 December, 2014 for the general public in Sweden and from 21 November, 2014 until 3 December, 2014 for institutional investors · Expected first day of trading on Nasdaq Stockholm is 12 December, 2014 Jens Engwall, CEO, comments: ”Hemfosa’s clear ambition is continued growth, in particular within the segment community service properties. In line with this we seek to have access to expansion capital for potential acquisitions. We view preference shares as an attractive complement to our existing sources of financing and deem that our property portfolio with stable cash flows is well suited to be partly financed by preference shares.” Background and reasons Hemfosa is a Swedish real estate company which combines long-term property management with an active role on the property transaction market. The Company’s ambition is to capture the opportunities of a changing property market, to create stable revenue streams and to generate high returns. At the same time, Hemfosa shall be a responsible and receptive landlord which provides excellent service to its customers. The Company was founded in June 2009 by the CEO Jens Engwall, with a background from transaction intensive and value creating property companies. Hemfosa has since then established a balanced portfolio of commercial properties in Sweden, of which a large share is comprised of community service properties with government and municipal bodies as the largest tenants. The total property value amounted to approximately SEK 20.6 billionas of 30 September, 2014, including the Company’s share of the property value in joint ventures. Hemfosa’s strategy is to focus on long-term growth of the Company’s cash flows by actively managing and improving the existing property portfolio. The Company creates and maintains long-term relationships with its tenants by assuming a market oriented and adept property management. In addition, Hemfosa intends to participate actively on the transaction market to create growth by focusing on community service properties, to risk optimise its property portfolio in terms of e.g. geography, property segment and tenant structure as well as to generate profits from the transaction business. In connection to the listing of Hemfosa’s shares in March 2014, Hemfosa communicated its intention to evaluate the possibility to raise additional expansion capital through, for example, the issue of preference shares or the issue of bonds. During the spring, Hemfosa successfully completed a three year SEK 1,200m unsecured bond issue. Hemfosa’s Board of Directors deems that a preference share issue implies improved financial possibilities for continued growth while still maintaining an appropriate proportion of equity. From the proceeds of SEK 975m, approximately SEK 700m is intended for Hemfosa’s, signed but not closed, property acquisitions from Castellum and Hemsö with a total property value of approximately SEK 2bn and SEK 3.3bn respectively, that was announced by Hemfosa on 17 November, 2014 and on 18 November, 2014. The remaining part of the proceeds, including any additional proceeds if the Offer is increased, is to be used for investments in the existing property portfolio as well as further property acquisitions which are continuously evaluated by the Company in its day-to-day operations. Greater access to capital will expand the Company’s opportunities for financing the Company’s growth, and facilitates an active and opportunistic role in the transaction market. The Offer The Offer includes up to 3,000,000 preference shares with a subscription price of SEK 325 per preference share, corresponding to total proceeds of up to SEK 975m before issue expenses. Minimum subscription is set to 50 preference shares, further subscription can be made in even lots of 10 preference shares. The subscription period runs from 21 November, 2014 until 2 December, 2014 for the general public in Sweden and from 21 November, 2014 until 3 December, 2014 for institutional investors. Assuming that the Offer is fully subscribed the number of shares in the Company will increase by 3,000,000 preference shares and the number of votes will increase by 300,000, corresponding to a dilution of approximately 4.6 per cent of the shares and approximately 0.5 per cent of the votes. The Board of Directors may decide, until and including the announcement date estimated to 4 December, 2014, to increase the Offer by up to 2,000,000 additional preference shares up to 5,000,000 preference shares in total. Hereby, as a part of the Offer, Hemfosa could receive additional proceeds of up to SEK 650m. The Offer shall be directed, with deviation from the shareholders' preferential rights, to the general public in Sweden and institutional investors in Sweden and internationally, including Hemfosa’s existing shareholders. The reason for the deviation from the shareholders' preferential rights is that the Board of Directors of Hemfosa believes that the terms of a preference share issue directed to the general public in Sweden and institutional investors, including Hemfosa’s existing shareholders, are more favorable compared to other alternatives. Please see the prospectus that is to be published for complete terms and conditions in the Offer. Prospectus and information brochure Hemfosa has with regard to the Offer prepared a prospectus and an information brochure that are to be published as soon as approval is obtained from the Swedish Financial Supervisory Authority, which is expected to occur during today. The prospectus, the information brochure and the application form can be obtained from Hemfosa and Swedbank. The prospectus, the information brochure and the application form will also be available on Hemfosa’s website (www.hemfosa.se) and Swedbank’s website (www.swedbank.se/prospectus). Applications can also be made through Avanza or Nordnet. The information brochure will be distributed to Hemfosa’s shareholders. Preliminary timetable Subscription period (general public in Sweden) 21 November – 2 December, 2014 Subscription period (institutional investors) 21 November – 3 December, 2014 Announcement date 4 December, 2014 Settlement date 8 December, 2014 Paid subscription shares (BTA) on VP-account/depositary account (institutional investors) 8 December, 2014 Paid subscription shares (BTA) on VP-account/depositary account (general public in Sweden) 9 December, 2014 First day of trading on Nasdaq Stockholm 12 December, 2014 Advisors Swedbank Corporate Finance is acting as financial advisor and Advokatfirman Cederquist as legal advisor to Hemfosa in connection to the Offer. Nacka 20 November, 2014 Hemfosa Fastigheter AB (publ) The Board of Directors Important notice This announcement is not an offer to sell or a solicitation of any offer to buy any securities issued by Hemfosa Fastigheter AB in any jurisdiction where such offer or sale would be unlawful and the announcement and the information contained herein are not for distribution or release, directly or indirectly, in or into such jurisdictions. In any EEA member state, other than Sweden, that has implemented Directive 2003/71/EC as amended (together with any applicable implementing measures in any member state, the “Prospectus Directive”), this communication is only addressed to and is only directed at qualified investors in that member state within the meaning of the Prospectus Directive. Any securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States. Any securities sold in the United States will be sold only to qualified institutional buyers (as defined in Rule 144A under the Securities Act) pursuant to Rule 144A. This announcement does not constitute a prospectus and nothing herein contains an offering of securities. No one should purchase or subscribe for any securities in the Company, except on the basis of information in any prospectus published by the Company in connection with the potential offering and admission of such securities to trading and official listing on NASDAQ OMX Stockholm. Copies of any such prospectus will, following publication, be available on the website of the Company. Matters discussed in this release may constitute forward-looking statements. Forward-looking statements are statements that are not historical facts and that can be identified by words such as “believe”, “expect”, “anticipate”, “intends”, “estimate”, “will”, “may”, “continue”, “should”, and similar expressions. The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although the Company believes that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties, contingencies and other important factors which are difficult or impossible to predict and are beyond its control. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this release by such forward-looking statements. The information, opinions and forward-looking statements contained in this release speak only as at its date, and are subject to change without notice. For more information, please contact: Bengt Kjell, Chairman of the Board, mobile: +46 705 94 5398 Jens Engwall, CEO, jens.engwall@hemfosa.se, mobile: +46 706 90 6550, office +46 8 448 04 80 About Hemfosa Fastigheter Hemfosa is a Swedish property company with a property portfolio characterized by a balanced geographic spread and a high proportion of community service properties with the government and municipalities as the largest tenants. This generates stable revenue flows and a healthy yield. Hemfosa also aims to create value by actively participating in the transaction market. As of 30 September, 2014, Hemfosa owns commercial properties in Sweden with a total property value of approximately SEK 20.6 billion, including the Company’s share of the property value in joint ventures. The Company’s share is listed on the Nasdaq Stockholm Mid Cap exchange as of 21 March, 2014.
Hemfosa announces preference share issue of SEK 975m The
Top 10 Most Recent News Articles
MERSCO’s Holiday Push Tests Backyard Play Demand in 2026
A trampoline sale is not exactly a macroeconomic bellwether, but it does expose a useful little corner of holiday spending: parents buying big, awkward, discretionary stuff that has to earn its space in the yard. MERSCO is joining Amazon’s Black Friday and Cyber Monday window from November 19 through November 30, 2026, with discounts reaching 38% on selected products....
Continue Reading
Markley’s Lowell Campus Turns Data Land Into Arboretum
Server halls rarely get credited with restoring a landscape, which is why Markley’s Lowell campus caught my eye. On November 18, 2026, the company said its Lowell data center campus had earned Level I arboretum accreditation from the ArbNet Arboretum Accreditation Program. ArbNet describes itself as the only international accreditation program specifically for arboreta,...
Continue Reading
America's Group Adds Swansea to Its UK Auction Map
A Welsh Lane Joins a Larger Road Port Talbot just became a small but telling dot on America's Group's international map. The company has acquired Swansea Motor Vehicle Auction Limited, a long-standing South Wales wholesale and remarketing operation, and plans to run it under the G3 brand. This is not the sort of deal that makes markets levitate. It is the sort that tells...
Continue Reading
Volta M100 Puts Flexibility at Pad Printing's Center
A tabletop printer rarely earns a second glance, but the Volta M100 is making a sensible argument: small manufacturers do not need another rigid box that becomes obsolete the minute a job changes. Boston Industrial Solutions has introduced the Volta M100 as a pad-printing machine built around adjustability, operator convenience, and software that can be upgraded as...
Continue Reading
Lummus-Versalis Deal Adds Nine Elastomer Technologies
Nine elastomer technologies do not make a flashy headline, yet this is the sort of chemical-industry move that can matter long after the applause dies down. Lummus Technology and Versalis have expanded their partnership to cover nine elastomer technologies. That is the disclosed fact, and it is meaningful on its own. The release does not lay out contract value, duration,...
Continue Reading
Workday GO for Financials Targets the Messy Middle
Spreadsheets rarely die gracefully; they get buried under approvals, reconciliations, and the frantic scavenger hunt before an audit. Workday is aiming straight at that unpleasant moment with Workday GO for Financials, announced November 18 at Workday Rising EMEA in Barcelona. The pitch is not terribly romantic, thank goodness. It is a simpler way for growing companies to...
Continue Reading
RazorMetrics' Fast 500 Run Merits a Harder Investor Look
A 4,488% growth figure can make even a seasoned skeptic sit upright. RazorMetrics landed at No. 20 on Deloitte's 2026 Technology Fast 500 after ranking No. 12 in 2025, and it again took the top Texas slot. That is serious momentum for an Austin company working on one of healthcare's most stubborn expenses: prescription drugs. Still, this is healthcare cost containment,...
Continue Reading
Mantle's Japan Listing Puts $MNT Through a Real Test
Japan's crypto gatekeepers just handed Mantle a key, not a crown. The November 18 listing of $MNT on GMO Coin is a meaningful operational win because getting onto a Japanese centralized exchange is not the usual loose-change exercise seen in friendlier jurisdictions. Mantle cleared a review process involving GMO Coin and the Japan Virtual and Crypto Assets Exchange...
Continue Reading
Anycubic Pushes Toward a Smoother 3D Printing Ecosystem
Friction Is the Enemy in Consumer 3D Printing A printer that makes a beautiful object only after three failed attempts is not a consumer product; it is a weekend argument with plastic. That is the useful lens for Anycubic's Formnext 2026 showing in Frankfurt on November 18. The company is not merely rolling out FDM and resin machines at Booth F01 in Hall 12.0. It is...
Continue Reading
Three Deal Reviews Put Merger Terms Under Scrutiny
Three proposed transactions just picked up the sort of legal glare boards hate seeing. A shareholder-rights firm, Halper Sadeh, said on November 18, 2026 that it is investigating whether the deals involving Greenland Energy, Rapid Micro Biosystems and Aytu BioPharma may involve federal securities-law violations or breaches of fiduciary duty. That is an allegation worth...
Continue ReadingTop 5 Most Recently Viewed Articles
Ford Motor Company Faces Legal Challenges: Key Insights
Understanding the Legal Landscape for Ford Motor Company As investors navigate the intricate world of stock ownership, recent events surrounding Ford Motor Company have raised eyebrows. The company currently finds itself at the center of a class action lawsuit involving shareholders who acquired stock during a specific period. Class Action Overview and Important Dates...
Continue Reading
Transforming the Specialty Fats and Oils Industry for Success
A Deep Dive into the Specialty Fats and Oils Market The landscape of the specialty fats and oils market is rapidly transforming, growing from its valuation of US$ 16.12 billion in the preceding year to a staggering US$ 31.69 billion by 2033, marking a robust CAGR of 7.8% during the next financial stretch. This growth signals a significant shift in industry dynamics and...
Continue Reading
C3.ai: Analyzing Current Trends in the Options Market
Current Sentiment on C3.ai Recently, well-known investors—often referred to as whales—have taken a decidedly negative stance towards C3.ai. This growing skepticism stems from the history of options involving the company's stock. An analysis of C3.ai's (AI) trading patterns uncovered nine notable trades. Digging deeper into these transactions shows that only 22% of...
Continue Reading
CytomX Therapeutics Completes $100 Million Stock Offering
CytomX Therapeutics Completes $100 Million Stock Offering CytomX Therapeutics, Inc. (NASDAQ: CTMX), based in South San Francisco, has just announced the pricing of an extensive stock offering. The company is set to offer 76,923,076 shares of its common stock at a price of $1.30 per share. This significant transaction aims to raise approximately $100 million and is being...
Continue Reading
Wall Street's Bullish Coverage Initiation Highlights for NKE and Others
Wall Street Analysts Initiate Coverage on Key Stocks In a dynamic market landscape, top analysts have recently adjusted their ratings on several prominent companies. Their insights provide a glimpse into potential future performance for investors. Today, we spotlight these analyst ratings and what they mean for some notable stocks. NIKE, Inc. (NKE) Coverage by Needham...
Continue Reading